GlassScriptPhysician profile
Carlos M Yu
NPI 1417934894
$11,435.86
in general payments reported to CMS, 2019-2025
83 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,515 · 2020: $1,827 · 2021: $2,148 · 2022: $2,026 · 2023: $1,420 · 2024: $1,154 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,840 · Education: $79.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,839.93 |
| Education | $79.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,251.96 | 2019-2025 | Botox, Ubrelvy, Qulipta |
| Novo Nordisk INC | $693.90 | 2019-2025 | Ozempic, Rybelsus |
| Allergan, INC. | $584.58 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $451.28 | 2019-2022 | |
| Ucb, INC. | $430.30 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Eisai INC. | $381.98 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $371.75 | 2019-2023 | |
| Genzyme Corporation | $357.55 | 2019-2023 | |
| Biogen, INC. | $330.16 | 2019-2023 | Plegridy, Vumerity |
| Emd Serono, INC. | $323.50 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $276.20 | 2019-2025 | Austedo Xr, Austedo Xr |
| Sk Life Science, INC. | $275.58 | 2020-2024 | |
| Dexcom, INC. | $263.47 | 2021-2025 | Dexcom G6 Transmitter |
| Sunovion Pharmaceuticals INC. | $236.34 | 2019-2021 | |
| Lilly USA, LLC | $197.27 | 2019-2025 | Jardiance |
Show all 83 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.